4.92

2.50% 0.12

After Hours: 4.92

Orchestra Biomed Holdings Inc (OBIO)

Overview News Price History Discussions Forecast

Orchestra Biomed Holdings Inc stock is traded at $4.92, with a volume of 178.72K. It is up +2.50% in the last 24 hours and down -6.82% over the past month. Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Previous Close:

$4.80

Open:

$4.64

24h Volume:

178.72K

Relative Volume:

3.18

Market Cap:

$186.10M

Revenue:

$2.76M

Net Income/Loss:

$-49.12M

P/E Ratio:

-4.1716

EPS:

-1.1794

Net Cash Flow:

$-46.21M

1W Performance:

-6.46%

1M Performance:

-6.82%

6M Performance:

-16.47%

1Y Performance:

-49.80%

1-Day Range:

$4.49

$4.98

1-Week Range:

$4.36

$5.305

52-Week Range:

$4.22

$10.44

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name

Orchestra Biomed Holdings Inc

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

646-343-9298

Address

150 UNION SQUARE DRIVE, NEW HOPE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

OBIO's Discussions on Twitter

Compare OBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OBIO Orchestra Biomed Holdings Inc	4.92	186.10M	2.76M	-49.12M	-46.21M	-1.50
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-22-24	Initiated	H.C. Wainwright	Buy
Jul-25-24	Initiated	B. Riley Securities	Buy
Jan-19-24	Initiated	Jefferies	Buy
Feb-24-23	Initiated	Piper Sandler	Overweight
Feb-07-23	Initiated	Chardan Capital Markets	Buy

Orchestra Biomed Holdings Inc Stock (OBIO) Latest News

Dec 20, 2024

Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com

Dec 20, 2024

Dec 19, 2024

Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 5,000 Shares of Stock - MarketBeat

Dec 19, 2024

Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com South Africa

Dec 19, 2024

Orchestra Biomed CEO David Hochman buys $24,550 in stock - Investing.com

Dec 19, 2024

Dec 18, 2024

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 18, 2024

Dec 17, 2024

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock Position Lowered by The Manufacturers Life Insurance Company - Defense World

Dec 17, 2024

Dec 11, 2024

(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 11, 2024

Dec 09, 2024

OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Dec 09, 2024

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - GlobeNewswire

Dec 09, 2024

Orchestra BioMed to Present Breakthrough AVIM Therapy Data for Hypertension Treatment at ICI 2024 - StockTitan

Dec 09, 2024

Dec 08, 2024